tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Financial Statements

287 Followers

Keros Therapeutics Financial Overview

Keros Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.206; its P/E ratio is -3.25; Keros Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-1.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 388.00K$ 37.00K$ 83.00K$ 143.00K$ 8.00K
Gross Profit$ 388.00K$ 37.00K$ 83.00K$ 143.00K$ 8.00K
EBIT$ -52.96M$ -45.26M$ -43.11M-$ -39.44M
EBITDA$ -52.08M$ -44.60M$ -42.50M-$ -39.23M
Net Income Common Stockholders$ -52.96M$ -45.26M$ -43.11M$ -40.24M$ -39.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 530.70M$ 405.90M$ 442.40M$ 331.15M$ 287.90M
Total Assets$ 579.27M$ 455.02M$ 485.82M$ 370.02M$ 326.25M
Total Debt$ 19.29M$ 13.96M$ 14.20M$ 14.44M$ 14.31M
Net Debt$ -511.41M$ -391.94M$ -428.20M$ -316.70M$ -273.58M
Total Liabilities$ 46.44M$ 34.11M$ 31.87M$ 37.81M$ 30.41M
Stockholders Equity$ 532.84M$ 420.92M$ 453.95M$ 332.21M$ 295.84M
Cash Flow-
Free Cash Flow$ -30.89M$ -40.11M$ -45.51M-$ -34.53M
Operating Cash Flow$ -30.50M$ -39.80M$ -44.56M$ -25.46M$ -33.98M
Investing Cash Flow$ -386.00K$ -310.00K$ -946.00K$ -541.00K$ -550.00K
Financing Cash Flow$ 155.94M$ 3.53M$ 156.80M$ 69.25M$ 284.00K
Currency in USD

Keros Therapeutics Earnings and Revenue History

Keros Therapeutics Debt to Assets

Keros Therapeutics Cash Flow

Keros Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis